Although immunotherapy for melanoma that enhances endogenous effector T cell response has yielded promising clinical results,224–228 further studies are needed to determine specifically whether the reduction of chemokine production and the population of CD4+ and CD8+ T cells producing INF-γ directly affect tumor growth. This evidence concerns the gene CD8A and neoplasm.